Site Map

Chronic lymphocytic leukemia (CLL)

CLL; Leukemia - chronic lymphocytic (CLL); Blood cancer - chronic lymphocytic leukemia; Bone marrow cancer - chronic lymphocytic leukemia; Lymphoma - chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) is cancer of a type of white blood cells called lymphocytes. These cells are found in the bone marrow and other parts of the body. Bone marrow is the soft tissue in the center of bones that helps form all blood cells.

CLL causes a slow increase in a certain type of white blood cells called B lymphocytes, or B cells. Cancer cells spread through the blood and bone marrow. CLL can also affect the lymph nodes or other organs such as the liver and spleen. CLL eventually can cause the bone marrow to lose its function.

Images

Bone marrow aspiration
Auer rods
Chronic lymphocytic leukemia - microscopic view
Antibodies

I Would Like to Learn About:

Causes

The cause of CLL is unknown. There is no link to radiation exposure. It is unclear if certain chemicals can cause CLL. Exposure to Agent Orange during the Vietnam War has been linked to a slight increased risk for developing CLL.

CLL usually affects older adults, especially those over age 60. People under age 45 rarely develop CLL. CLL is more common in white people than in people of other races. It is more common in men than in women. Some people with CLL have family members with the disease.

Symptoms

Symptoms usually develop slowly. CLL often does not cause symptoms at first. It may be found by blood tests done in people for other reasons.

Symptoms of CLL may include:

Exams and Tests

Your health care provider will perform a physical exam and ask about your symptoms.

Tests to diagnose CLL may include:

People with CLL usually have a high white blood cell count.

Tests that look at changes in the DNA inside the cancer cells may also be done. Results from these tests and from staging tests help your provider determine your treatment.

Treatment

If you have early stage CLL, your provider will just monitor you closely. Treatment is not generally given for early-stage CLL, unless you have:

Targeted therapy and sometimes chemotherapy are used to treat CLL. Your provider will determine which type of medicines are right for you.

Blood transfusions or platelet transfusions may be required if blood counts are low.

Bone marrow or stem cell transplantation may be used in younger people with advanced or high-risk CLL. A transplant is the only therapy that offers a potential cure for CLL, but it also has risks. Your provider will discuss the risks and benefits with you.

You and your provider may need to manage other concerns during your leukemia treatment, including:

Support Groups

You can ease the stress of illness by joining a cancer support group. Sharing with others who have common experiences and problems can help you not feel alone.

Outlook (Prognosis)

Your provider can discuss with you the outlook of your CLL based on its stage and how well it responds to treatment.

Possible Complications

Complications of CLL and its treatment may include:

When to Contact a Medical Professional

Contact your provider if you develop enlarged lymph nodes or unexplained fatigue, bruising, excessive sweating, or weight loss.

Related Information

Malignancy
Immunodeficiency disorders
Immune thrombocytopenic purpura (ITP)
Antibody
Bone marrow transplant
Bone marrow transplant - discharge

References

Awan FT, Byrd JC. Chronic lymphocytic leukemia. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, eds. Abeloff''s Clinical Oncology. 6th ed. Philadelphia, PA: Elsevier; 2020:chap 99.

National Cancer Institute website. Chronic lymphocytic leukemia treatment (PDQ) - health professional version. www.cancer.gov/types/leukemia/hp/cll-treatment-pdq. Updated December 8, 2023. Accessed May 7, 2024.

National Comprehensive Cancer Network website. NCCN clinical practice guidelines in oncology. Chronic lymphocytic leukemia/small lymphocytic lymphoma. Version 3. 2024. www.nccn.org/professionals/physician_gls/pdf/cll.pdf. Updated March 26, 2024. Accessed May 7, 2024.

BACK TO TOP

Review Date: 3/31/2024  

Reviewed By: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

© 1997-2024adam.com All rights reserved.